Cargando…
Technology transfer and scale down model development strategy for biotherapeutics produced in mammalian cells
Autores principales: | Kochanowski, Nadine, Malphettes, Laetitia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981586/ http://dx.doi.org/10.1186/1753-6561-7-S6-P86 |
Ejemplares similares
-
ambr™ Mini-bioreactor as a high-throughput tool for culture process development to accelerate transfer to stainless steel manufacturing scale: comparability study from process performance to product quality attributes
por: Delouvroy, Frédéric, et al.
Publicado: (2015) -
Evaluation of the advanced micro-scale bioreactor (ambr™) as a highthroughput tool for cell culture process development
por: Delouvroy, Frédéric, et al.
Publicado: (2013) -
Host cell protein platform assay development for therapeutic mAb bioprocessing using mammalian cells
por: Kochanowski, Nadine, et al.
Publicado: (2015) -
Scale-up considerations for monoclonal antibody production process: an oxygen transfer flux approach
por: Gimenez, Laura, et al.
Publicado: (2013) -
Process development and optimization of fed-batch production processes for therapeutic proteins by CHO cells
por: Clincke, Marie-Françoise, et al.
Publicado: (2013)